{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:19:26Z","timestamp":1770441566172,"version":"3.49.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","theclinics.com","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.cll.2014.08.007","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T11:17:18Z","timestamp":1412162238000},"page":"787-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges"],"prefix":"10.1016","volume":"34","author":[{"given":"Zain","family":"Kassam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.cll.2014.08.007_bib1","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.cll.2014.08.007_bib2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jamcollsurg.2014.01.053","article-title":"Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiaries","volume":"218","author":"Collins","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.cll.2014.08.007_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3201\/eid1406.071447","article-title":"Increase in adult Clostridium difficile\u2013related hospitalizations and case-fatality rate, United States, 2000\u20132005","volume":"14","author":"Zilberberg","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.cll.2014.08.007_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1086\/596703","article-title":"Health care\u2018 associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian nosocomial infection surveillance program study","volume":"48","author":"Gravel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9759","key":"10.1016\/j.cll.2014.08.007_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","article-title":"Clostridium difficile infection in Europe: a hospital-based survey","volume":"377","author":"Bauer","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cll.2014.08.007_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/trstmh\/tru042","article-title":"Detection of Clostridium difficile diarrhoea in Harare, Zimbabwe","volume":"108","author":"Simango","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.cll.2014.08.007_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2012.02.004","article-title":"Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of health care-facility-acquired infection","volume":"81","author":"Wiegand","year":"2012","journal-title":"J\u00a0Hosp Infect"},{"issue":"3","key":"10.1016\/j.cll.2014.08.007_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1469-0691.2011.03571.x","article-title":"The economic burden of Clostridium difficile","volume":"18","author":"McGlone","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2014.08.007_bib9","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/cid\/cis335","article-title":"Burden of Clostridium difficile on the health care system","volume":"55","author":"Dubberke","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cll.2014.08.007_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhin.2008.05.004","article-title":"Cost of nosocomial Clostridium difficile-associated diarrhoea","volume":"70","author":"Vonberg","year":"2008","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cll.2014.08.007_bib11","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile \u2014 more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cll.2014.08.007_bib12","doi-asserted-by":"crossref","first-page":"e53757","DOI":"10.1371\/journal.pone.0053757","article-title":"Characterization of a stable, metronidazole-resistant clostridium difficile clinical isolate","volume":"8","author":"Lynch","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cll.2014.08.007_bib13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/jac\/dkn313","article-title":"Emergence of reduced susceptibility to metronidazole in Clostridium difficile","volume":"62","author":"Baines","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.cll.2014.08.007_bib14","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.46.6.1647-1650.2002","article-title":"Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin","volume":"46","author":"Pel\u00e1ez","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.cll.2014.08.007_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s15010-013-0496-x","article-title":"Treatment of recurrent Clostridium difficile infection: a systematic review","volume":"42","author":"O\u2019Horo","year":"2014","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.cll.2014.08.007_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/cid\/cis430","article-title":"Decreased cure and increased recurrence rates for clostridium difficile infection caused by the epidemic C. difficile BI strain","volume":"55","author":"Petrella","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2014.08.007_bib17","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/JCM.38.6.2386-2388.2000","article-title":"Epidemiology of recurrences or reinfections of Clostridium difficile epidemiology of recurrences or reinfections of Clostridium difficile -associated diarrhea","volume":"38","author":"Barbut","year":"2000","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.cll.2014.08.007_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.cll.2014.08.007_bib19","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.cll.2014.08.007_bib20","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"McFarland","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cll.2014.08.007_bib21","doi-asserted-by":"crossref","first-page":"e81330","DOI":"10.1371\/journal.pone.0081330","article-title":"Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"8","author":"Song","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cll.2014.08.007_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/525047","article-title":"Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea","volume":"197","author":"Chang","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.cll.2014.08.007_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MCG.0b013e3181c87e02","article-title":"Khoruts 2010","volume":"44","author":"Khoruts","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.cll.2014.08.007_bib24","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/ajg.2012.251","article-title":"Should we standardize the 1,700-year-old fecal microbiota transplantation?","volume":"107","author":"Zhang","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cll.2014.08.007_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cll.2014.08.007_bib26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1365-2036.2012.05033.x","article-title":"Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease","volume":"35","author":"Guo","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.cll.2014.08.007_bib27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/cid\/cir632","article-title":"Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent clostridium difficile infection","volume":"53","author":"Gough","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.cll.2014.08.007_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/apt.12699","article-title":"Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children","volume":"39","author":"Sha","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cll.2014.08.007_bib29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/506290a","article-title":"How to regulate faecal transplants","volume":"506","author":"Smith","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cll.2014.08.007_bib30","first-page":"1","article-title":"Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy","volume":"28","author":"Moayyedi","year":"2014","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cll.2014.08.007_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40124-014-0040-1","article-title":"Navigating the pediatric microbiome: emerging evidence and clinical implications","volume":"2","author":"Kassam","year":"2014","journal-title":"Curr Pediatr Rep"},{"issue":"5","key":"10.1016\/j.cll.2014.08.007_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"Van Nood","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.cll.2014.08.007_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciu135","article-title":"Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study","volume":"58","author":"Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.cll.2014.08.007_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciu128","article-title":"Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis","volume":"58","author":"Konijeti","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.cll.2014.08.007_bib35","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1001\/archinte.172.2.191","article-title":"Fecal transplant via retention enema for refractory or recurrent clostridium difficile infection","volume":"172","author":"Kassam","year":"2012","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.cll.2014.08.007_bib36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/j.gastro.2011.11.037","article-title":"Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection","volume":"142","author":"Mattila","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cll.2014.08.007_bib37","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ajg.2014.133","article-title":"Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients","volume":"109","author":"Kelly","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cll.2014.08.007_bib38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for health care epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.cll.2014.08.007_bib39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cll.2014.08.007_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"Comm. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.cll.2014.08.007_bib41","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.cll.2014.08.007_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1155\/2012\/213828","article-title":"A\u00a0Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics","volume":"26","author":"Allen-Vercoe","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cll.2014.08.007_bib43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s10096-014-2088-9","article-title":"The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema","volume":"33","author":"Lee","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.cll.2014.08.007_bib44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mib.2013.06.004","article-title":"The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications","volume":"16","author":"Collins","year":"2013","journal-title":"Curr Opin Microbiol"},{"issue":"8","key":"10.1016\/j.cll.2014.08.007_bib45","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/ajg.2013.164","article-title":"Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts","volume":"108","author":"Schwartz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cll.2014.08.007_bib46","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ajg.2012.60","article-title":"Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection","volume":"107","author":"Brandt","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cll.2014.08.007_bib47","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ajg.2013.214","article-title":"Navigating long-term safety in fecal microbiota transplantation","volume":"108","author":"Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cll.2014.08.007_bib48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/367657","article-title":"Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube","volume":"36","author":"Aas","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.cll.2014.08.007_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cgh.2010.01.007","article-title":"Success of self-administered home fecal transplantation for chronic Clostridium difficile infection","volume":"8","author":"Silverman","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cll.2014.08.007_bib50","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MCG.0b013e3181dac035","article-title":"Treatment of refractory\/recurrent C. difficile- associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients","volume":"44","author":"Yoon","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cll.2014.08.007_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MCG.0b013e318234570b","article-title":"Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results","volume":"46","author":"Kelly","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.cll.2014.08.007_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.mcg.0000128988.13808.dc","article-title":"Bacteriotherapy using fecal flora","volume":"38","author":"Borody","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"17","key":"10.1016\/j.cll.2014.08.007_bib53","first-page":"1027","article-title":"Clostridium difficile-associated diarrhea treated with homologous feces","volume":"118","author":"Lund-T\u00f8nnesen","year":"1998","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"5","key":"10.1016\/j.cll.2014.08.007_bib54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ajg.2011.482","article-title":"Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection","volume":"107","author":"Hamilton","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"11\u201312","key":"10.1016\/j.cll.2014.08.007_bib55","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3109\/00365548.2010.499541","article-title":"Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea","volume":"42","author":"Garborg","year":"2010","journal-title":"Scand J Infect Dis"},{"issue":"8354","key":"10.1016\/j.cll.2014.08.007_bib56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(83)90753-5","article-title":"Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces","volume":"2","author":"Schwan","year":"1983","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cll.2014.08.007_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2049-2618-1-3","article-title":"Stool substitute transplant therapy for the eradication of Clostridium difficile infection: \u201cRePOOPulating\u201d the gut","volume":"1","author":"Petrof","year":"2013","journal-title":"Microbiome"},{"key":"10.1016\/j.cll.2014.08.007_bib58","unstructured":"Louie T, Cannon K, O\u2019Grady H, et\u00a0al. Fecal microbiome transplantation (FMT) via oral fecal microbial capsules for recurrent Clostridium difficile infection (rCDI). Abstract presented at The ID Week Conference. 2014."},{"key":"10.1016\/j.cll.2014.08.007_bib59","unstructured":"Kelly C. Fecal transplant for relapsing C. Difficile infection. 2014. U.S. National Institutes of Health Trial Register. NCT Number 01703494. Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01703494?term=fecal+transplant & rank=4. Accessed July 14, 2014."},{"key":"10.1016\/j.cll.2014.08.007_bib60","unstructured":"Hohmann EL. Fecal microbiota transplant for relapsing Clostridium difficile infection in adults and children using a frozen encapsulated inoculum. 2014. U.S. National Institutes of Health Trial Register. NCT Number NCT01914731. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01914731?term=fecal&rank=17. Accessed July 14, 2014."},{"key":"10.1016\/j.cll.2014.08.007_bib61","unstructured":"Lee C. Multi-centre trial of fresh vs frozen-and-thawed HBT (fecal transplant) for recurrent CDI. 2014. Available at: U.S. National Institutes of Health Trial Register. NCT Number 01398969. Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01398969?term=fecal+transplant & rank=2. Accessed July 14, 2014."},{"key":"10.1016\/j.cll.2014.08.007_bib62","unstructured":"Hota S. Oral vancomycin followed by fecal transplant vs. tapering oral vancomycin. 2014. U.S. National Institutes of Health Trial Register. NCT Number 01226992. Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01226992?term=feca l+transplant & rank=1. Accessed July 12, 2014."},{"key":"10.1016\/j.cll.2014.08.007_bib63","unstructured":"Gisser J. Fecal transplant for pediatric patients who have recurrent C-diff infection (FMT). 2014. Available at: U.S. National Institutes of Health Trial Register. NCT Number NCT02134392. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02134392?term=gisser&rank=1. Accessed July 12, 2014."},{"issue":"10","key":"10.1016\/j.cll.2014.08.007_bib64","doi-asserted-by":"crossref","first-page":"e1002995","DOI":"10.1371\/journal.ppat.1002995","article-title":"Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice","volume":"8","author":"Lawley","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cll.2014.08.007_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000000415","article-title":"Fecal microbial therapy - promises and pitfalls","author":"Merenstein","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cll.2014.08.007_bib66","unstructured":"Smith M, Kassam Z, Edelstein C, et\u00a0al. OpenBiome. 2014. Available at: http:\/\/www.openbiome.org\/. Accessed July, 2014."},{"key":"10.1016\/j.cll.2014.08.007_bib67","unstructured":"FDA. Vaccine and Related Biological Product Guidances - draft guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. 2014. Available at: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/Vaccines\/ucm387023.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery. Accessed September 18, 2014."}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271214000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271214000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T15:13:34Z","timestamp":1650294814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271214000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0272271214000821"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2014.08.007","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2014.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}